A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults

Vaccine

Volumn 21, Issue 32, 2003, Pages 4650-4654

  Beran, Jiří ^a   Chlibek, Roman ^b   Weber, Françoise ^c  

^a Vaccination and Travel Medicine Centre   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^c SANOFI PASTEUR   (France)

Author keywords

Avaxim ; Combined vaccine; Hepatitis A; Typhoid fever; Vivaxim

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS A VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG; VIVAXIM;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG APPROVAL; DRUG DOSE; EDEMA; ERYTHEMA; FEMALE; FEVER; HEADACHE; HEMATOMA; HEPATITIS A; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MALAISE; MALE; MYALGIA; NAUSEA; NORMAL HUMAN; PAIN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INDURATION; TITRIMETRY; TRAVEL; VOMITING;

EID: 0142258054     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.08.013     Document Type: Article

References (15)

1. Glikson M., Galun E., Oren R., Tur-Kaspa R., Shouval D. Relapsing hepatitis A: review of 14 cases and literature survey. Medicine. 71:1992;14-23.
2. Andre F.E. Hepatitis A in travellers: development of a safe, immunogenic and efficacious inactivated vaccine. Travel Med. Int. 13:1995;10-14.
3. Anonymous. Typhoid vaccines - WHO position paper. Wkly Epidemiol Rec 2000;75:257-64.
4. Rowe B., Ward L.R., Threlfall E.J. Multidrug-resistant Salmonella typhi: a world-wide epidemic. Clin. Infect. Dis. 24:1997;106-109.
5. Plotkin S.A., Bouveret-Le Cam N.A. A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch. Int. Med. 155:1995;2293-2299.
6. Steffen R., Kane M.A., Shapiro C.N.et al. Epidemiology and prevention of hepatitis A in travellers. JAMA. 272:1994;885-889.
7. De Serres G., Duval B., Shadmani R.et al. Ineffectiveness of the current strategy to prevent hepatitis A in travellers. J. Travel Med. 9:2002;10-16.
8. Van Hoecke C., Lebacq E., Beran J., Primula R., Collard F. Concomitant vaccination against hepatitis A and typhoid fever. J. Travel Med. 5:1998;116-120.
9. Beran J., Beutels M., Levie K.et al. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity. J. Travel Med. 7:2000;246-252.
10. Proell S., Maiwaild H., Nothdurft H.-N.et al. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity. J. Travel Med. 9:2002;122-126.
11. Vodopija I.I., Baklaic Z., Vodopija R., Clemens R. Immune response to hepatitis A vaccine combined or given simultaneously with typhoid fever vaccine. J. Travel Med. 4:1997;114-117.
12. Overbosch D, Peyron F, Picot N, Varichon JP. Immunogenicity and safety of a combined typhoid fever and hepatitis A vaccine: a comparison of a combined vaccine in a dual-chamber syringe versus the monovalent vaccines. In: Proceedings of the Seventh International Conference of the International Society of Travel Medicine (Abstract FC07.03), 27-31 May 2001, lnnsbruck, Austria.
13. Beeching NJ, Clarke P, Walker E, et al. A comparison of two combined vaccines against typhoid fever and hepatitis A: Viatim™ and Hepatyrix™. In: Proceedings of the Fourth Scientific Conference of the British Travel Health Association. 2 March 2002, London, UK.
14. Tacket C.O., Ferreccio C., Robbins J.B.et al. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 154:1986;342-345.
15. Ambrosch F., Fritzell B., Gregor J.et al. Combined vaccination against yellow fever and typhoid fever: a comparative trial. Vaccine. 12:1994;625-628.